The Chemours Company Announces Upsizing and Pricing of Private Offering of $700,000,000 of 7.875% Senior Notes Due 2034
Rhea-AI Summary
Chemours (NYSE: CC) priced an upsized private offering of $700,000,000 aggregate principal amount of 7.875% senior notes due March 15, 2034, up from a previously announced $600,000,000.
Interest will be paid semi‑annually starting September 15, 2026; closing is expected March 12, 2026. Net proceeds are intended to fund redemptions of the company's 5.375% senior notes due 2027 and a partial redemption of its 5.750% senior notes due 2028.
Positive
- Capital raise of $700 million to address near‑term debt
- Proceeds earmarked to redeem 5.375% (2027) and partially redeem 5.750% (2028) notes
- Offering expected to close on March 12, 2026, providing quick execution certainty
Negative
- New coupon of 7.875% increases interest cost versus redeemed 5.375% and 5.750% notes
- Offering limited to qualified institutional buyers and Regulation S, restricting broad investor access
Key Figures
Market Reality Check
Peers on Argus
Sector peers showed mixed moves: ASH -0.18%, KWR -1.3%, IOSP -1.15%, MTX +0.74%, NGVT +7.01%. With no peers in the momentum scanner and dispersed directions, trading around this Chemours debt offering appeared stock-specific rather than part of a broad specialty chemicals move.
Previous Private placement,offering Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Nov 27 | Debt offering completion | Neutral | -0.4% | Completed $600M 8.000% notes due 2033 to redeem euro notes. |
| Nov 13 | Debt offering pricing | Neutral | +0.8% | Priced $600M 8.000% notes due 2033 at 8.000% interest. |
| Nov 13 | Debt offering announcement | Neutral | -0.7% | Announced plan to offer $600M senior notes due 2033. |
Similar private offerings over the past year saw limited price impact, with an average move of about -0.09% around such announcements.
Over recent private placement and offering events, Chemours repeatedly used senior unsecured notes to refinance existing debt. In November 2024, it announced and priced $600 million of 8.000% senior notes due 2033, followed by completion of that offering to redeem euro‑denominated 4.000% notes due 2026 and for general corporate purposes. Price reactions to these financing steps stayed modest (from -0.73% to +0.84%), suggesting markets treated them as routine balance sheet management.
Historical Comparison
In the last 12 months, Chemours issued 3 similar private offerings. Average next‑day move was about -0.09%, indicating historically muted equity reactions to such debt financings.
Chemours has consistently used senior unsecured note offerings, first for 2033 maturities refinancing euro 2026 notes and now for 2034 notes aimed at redeeming 2027 and 2028 senior notes, showing an ongoing debt maturity reprofiling pattern.
Market Pulse Summary
This announcement outlines a private offering of $700,000,000 in 7.875% senior notes due 2034, upsized from $600,000,000. Chemours plans to use proceeds to redeem 5.375% notes due 2027 and partially redeem 5.750% notes due 2028, continuing its pattern of managing debt maturities via senior unsecured notes. Key items to watch include closing on March 12, 2026, execution of the planned redemptions, and any follow‑on updates in future filings or earnings calls.
Key Terms
senior notes financial
qualified institutional buyers financial
rule 144a regulatory
regulation s regulatory
securities act regulatory
senior unsecured obligations financial
AI-generated analysis. Not financial advice.
WILMINGTON, Del., Feb. 26, 2026 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC) today announced the pricing of its previously announced private offering of
Chemours intends to use the net proceeds from the offering to fund the redemption of its outstanding
The Notes and related guarantees were offered only to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), or outside the United States to non-U.S. persons in compliance with Regulation S under the Securities Act. This press release shall not constitute an offer to sell or the solicitation of an offer to buy the Notes and related guarantees.
The Notes and related guarantees have not been registered under the Securities Act, or the securities laws of any other jurisdiction, and may not be offered or sold in
About The Chemours Company
The Chemours Company (NYSE: CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through our three businesses – Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials – we deliver application expertise and chemistry-based innovations that solve customers' biggest challenges. Our flagship products are sold under prominent brands such as Opteon™, Freon™, Ti-Pure™, Nafion™, Teflon™, Viton™, and Krytox™. Headquartered in
Forward-Looking Statements
This press release contains forward-looking statements, within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical or current fact. The words "believe," "expect," "will," "anticipate," "plan," "estimate," "target," "project" and similar expressions, among others, generally identify "forward-looking statements," which speak only as of the date such statements were made. These forward-looking statements may address, among other things, the closing of the offering of Notes and Chemours' intended use of the net proceeds therefrom, which are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These risks and uncertainties include, but are not limited to, the ability of Chemours to satisfy the conditions to closing the offering and general market conditions which may impact the closing of the offering. Forward-looking statements are based on certain assumptions and expectations of future events that may not be accurate or realized. These statements are not guarantees of future performance. Forward-looking statements also involve risks and uncertainties that are beyond Chemours' control. Matters outside Chemours' control, including general economic conditions, geopolitical conditions, changes in laws and regulations in
CONTACTS:
INVESTORS
Brandon Ontjes
Vice President, Investor Relations
+1.302.773.3309
investor@chemours.com
NEWS MEDIA
Cassie Olszewski
Media Relations & Reputation Leader
+1.302.219.7140
media@chemours.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/the-chemours-company-announces-upsizing-and-pricing-of-private-offering-of-700-000-000-of-7-875-senior-notes-due-2034--302699031.html
SOURCE The Chemours Company